Bacitracin Zinc and Polymyxin B Sulfate BACITRACIN ZINC AND POLYMYXIN B SULFATE A-S MEDICATION SOLUTIONS FDA Approved Bacitracin zinc and polymyxin B sulfate ophthalmic ointment, USP is a sterile antimicrobial ointment formulated for ophthalmic use. Bacitracin zinc is the zinc salt of bacitracin, a mixture of related cyclic polypeptides (mainly bacitracin A) produced by the growth of an organism of the licheniformis group of Bacillus subtilis var Tracy. It has a potency of not less than 40 bacitracin units/mg. The structural formula for bacitracin A is: Polymyxin B sulfate is the sulfate salt of polymyxin B 1 and B 2 , which are produced by the growth of Bacillus polymyxa (Prazmowski) Migula (Fam. Bacillaceae). It has a potency of not less than 6,000 polymyxin B units/mg, calculated on an anhydrous basis. The structural formulae are: Each gram contains: Actives: bacitracin zinc equal to 500 bacitracin units and polymyxin B sulfate equal to 10,000 polymyxin B units; Inactives: mineral oil and white petrolatum. bacitracinchemstructure polychemstructure
FunFoxMeds box
Substance Bacitracin Zinc
Route
OPHTHALMIC
Applications
ANDA064046
Product NDC
Package NDC

Drug Facts

Composition & Profile

Strengths
3.5 g
Quantities
0 count
Treats Conditions
Indications And Usage For The Treatment Of Superficial Ocular Infections Involving The Conjunctiva And Or Cornea Caused By Organisms Susceptible To Bacitracin Zinc And Polymyxin B Sulfate

Identifiers & Packaging

Container Type BOX
All Product Codes
UNII
89Y4M234ES 19371312D4
Packaging

HOW SUPPLIED Product: 50090-3274 NDC: 50090-3274-0 3.5 g in a TUBE / 1 in a CARTON; Bacitracin Zinc and Polymyxin B Sulfate Label Image

Package Descriptions
  • HOW SUPPLIED Product: 50090-3274 NDC: 50090-3274-0 3.5 g in a TUBE / 1 in a CARTON
  • Bacitracin Zinc and Polymyxin B Sulfate Label Image

Overview

Bacitracin zinc and polymyxin B sulfate ophthalmic ointment, USP is a sterile antimicrobial ointment formulated for ophthalmic use. Bacitracin zinc is the zinc salt of bacitracin, a mixture of related cyclic polypeptides (mainly bacitracin A) produced by the growth of an organism of the licheniformis group of Bacillus subtilis var Tracy. It has a potency of not less than 40 bacitracin units/mg. The structural formula for bacitracin A is: Polymyxin B sulfate is the sulfate salt of polymyxin B 1 and B 2 , which are produced by the growth of Bacillus polymyxa (Prazmowski) Migula (Fam. Bacillaceae). It has a potency of not less than 6,000 polymyxin B units/mg, calculated on an anhydrous basis. The structural formulae are: Each gram contains: Actives: bacitracin zinc equal to 500 bacitracin units and polymyxin B sulfate equal to 10,000 polymyxin B units; Inactives: mineral oil and white petrolatum. bacitracinchemstructure polychemstructure

Indications & Usage

For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin B sulfate.

Dosage & Administration

Apply the ointment every 3 or 4 hours for 7 to 10 days, depending on the severity of the infection. FOR OPHTHALMIC USE ONLY

Warnings & Precautions
WARNINGS Ophthalmic ointments may retard corneal healing.
Contraindications

This product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

Adverse Reactions

To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Storage & Handling

Storage Store between 15°-25°C (59°-77°F). KEEP TIGHTLY CLOSED. Keep out of reach of children Bausch + Lomb, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →